Search
Agios Pharmaceuticals Inc
AGIOAdd to Watchlist
30.020USD
-2.730-8.34%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.79BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Agios Pharmaceuticals Inc is 8.00, ranking 171 out of 385 in the Biotechnology & Medical Research industry. The average price target is 32.00, with a high of 48.00 and a low of 20.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
45.857
Target Price
+52.76%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Agios Pharmaceuticals Inc
AGIO
10
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Agios Pharmaceuticals Inc's expected revenue for the next quarter?
Agios Pharmaceuticals Inc's expected revenue is 41.64M.
What is Agios Pharmaceuticals Inc's price target?
Analysts forecast that Agios Pharmaceuticals Inc's price target is USD 32.00, with the highest forecast at USD 48.00 and the lowest forecast at USD 20.00.
How have Agios Pharmaceuticals IncAGIO's recent earnings per share performed?
The market expectation was USD -1.69, while Agios Pharmaceuticals IncAGIO's earnings per share (EPS) for the previous quarter was USD -1.69. EPS for the next quarter is expected at USD -1.39.
What is the analyst rating for Agios Pharmaceuticals Inc?
Based on the ratings of Agios Pharmaceuticals Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.